A comprehensive digital mental health screening tool for people with epilepsy: A feasibility study in UK outpatients

IF 4.6 Q2 MATERIALS SCIENCE, BIOMATERIALS ACS Applied Bio Materials Pub Date : 2024-10-20 DOI:10.1016/j.yebeh.2024.110103
Andrea Biondi , Alice A. Winsor , Candice Ebelthite , Jemima Onih , Susannah Pick , Timothy R. Nicholson , Deb K. Pal , Mark P. Richardson
{"title":"A comprehensive digital mental health screening tool for people with epilepsy: A feasibility study in UK outpatients","authors":"Andrea Biondi ,&nbsp;Alice A. Winsor ,&nbsp;Candice Ebelthite ,&nbsp;Jemima Onih ,&nbsp;Susannah Pick ,&nbsp;Timothy R. Nicholson ,&nbsp;Deb K. Pal ,&nbsp;Mark P. Richardson","doi":"10.1016/j.yebeh.2024.110103","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Mental health symptoms are common in people with epilepsy, impacting medication adherence, quality of life, and mortality. Early detection and timely interventions for mental health symptoms will be crucial for improved outcomes but the absence of standardized screening procedures and time constraints hinder regular assessment and management.</div></div><div><h3>Purpose</h3><div>To evaluate feasibility, acceptability and, value of a digital tool for identifying mental health symptoms in adult and paediatric epilepsy outpatients using electronic Patient-Reported Outcome Measures (ePROMs).</div></div><div><h3>Methods and materials</h3><div>The study used an established local platform (IMPARTS − Integrating Mental and Physical Healthcare: Research Training and Services) to develop an online tool using e-PROMS for a comprehensive mental health screen (psychiatric symptoms, neurodevelopmental traits, and psychosocial/behavioural risk factors) of people with epilepsy. Prior to attending the outpatient clinical epilepsy services at King’s College Hospital, participants were invited to complete the online screening tool through an SMS appointment link.</div></div><div><h3>Results</h3><div>Out of 1081 epilepsy patients (955 adults, 126 paediatric), 38.2% of adults and 51.6% of carers of paediatric patients accessed the ePROMs, with modest completion rates of 15% and 14%, respectively. Adults reported mild to significant anxiety (37.4%), minor to major depression symptoms (29.2%), and occasionally psychotic symptoms (11.1%). Adults with self-reported psychiatric symptoms reported significantly higher number of seizures, seizure burden, insomnia, autistic and ADHD traits and lower quality of life and perceived social support. Only 21% of those reporting psychiatric symptoms were receiving any form of mental health support. A large proportion of paediatric patients presented emotional/behavioural difficulties (32%), high impulsivity (38.8%), low self-esteem (27.7%), sleep difficulties (50%), comorbid neurodevelopmental syndromes (27.7%). Both groups reported good level of perceived social support.</div></div><div><h3>Conclusion</h3><div>Our epilepsy adapted IMPARTS e-PROMS allowed remote screening for mental health symptoms, neurodevelopmental and resilience factors. Integrating these tools into electronic patient records might enhance early identification and facilitate referral to appropriate care pathways.</div></div>","PeriodicalId":2,"journal":{"name":"ACS Applied Bio Materials","volume":null,"pages":null},"PeriodicalIF":4.6000,"publicationDate":"2024-10-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Applied Bio Materials","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1525505024004852","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"MATERIALS SCIENCE, BIOMATERIALS","Score":null,"Total":0}
引用次数: 0

Abstract

Background

Mental health symptoms are common in people with epilepsy, impacting medication adherence, quality of life, and mortality. Early detection and timely interventions for mental health symptoms will be crucial for improved outcomes but the absence of standardized screening procedures and time constraints hinder regular assessment and management.

Purpose

To evaluate feasibility, acceptability and, value of a digital tool for identifying mental health symptoms in adult and paediatric epilepsy outpatients using electronic Patient-Reported Outcome Measures (ePROMs).

Methods and materials

The study used an established local platform (IMPARTS − Integrating Mental and Physical Healthcare: Research Training and Services) to develop an online tool using e-PROMS for a comprehensive mental health screen (psychiatric symptoms, neurodevelopmental traits, and psychosocial/behavioural risk factors) of people with epilepsy. Prior to attending the outpatient clinical epilepsy services at King’s College Hospital, participants were invited to complete the online screening tool through an SMS appointment link.

Results

Out of 1081 epilepsy patients (955 adults, 126 paediatric), 38.2% of adults and 51.6% of carers of paediatric patients accessed the ePROMs, with modest completion rates of 15% and 14%, respectively. Adults reported mild to significant anxiety (37.4%), minor to major depression symptoms (29.2%), and occasionally psychotic symptoms (11.1%). Adults with self-reported psychiatric symptoms reported significantly higher number of seizures, seizure burden, insomnia, autistic and ADHD traits and lower quality of life and perceived social support. Only 21% of those reporting psychiatric symptoms were receiving any form of mental health support. A large proportion of paediatric patients presented emotional/behavioural difficulties (32%), high impulsivity (38.8%), low self-esteem (27.7%), sleep difficulties (50%), comorbid neurodevelopmental syndromes (27.7%). Both groups reported good level of perceived social support.

Conclusion

Our epilepsy adapted IMPARTS e-PROMS allowed remote screening for mental health symptoms, neurodevelopmental and resilience factors. Integrating these tools into electronic patient records might enhance early identification and facilitate referral to appropriate care pathways.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
针对癫痫患者的综合数字心理健康筛查工具:针对英国门诊患者的可行性研究。
背景:心理健康症状在癫痫患者中很常见,会影响服药依从性、生活质量和死亡率。早期发现和及时干预精神健康症状对改善疗效至关重要,但缺乏标准化筛查程序和时间限制阻碍了定期评估和管理。目的:评估使用电子患者报告结果测量(ePROMs)识别成人和儿童癫痫门诊患者精神健康症状的数字工具的可行性、可接受性和价值:该研究使用了一个已建立的本地平台(IMPARTS - 整合心理和生理医疗保健:研究培训与服务)开发了一种在线工具,使用电子报告结果量表(e-PROMS)对癫痫患者进行全面的心理健康筛查(精神症状、神经发育特征和心理社会/行为风险因素)。在前往国王学院医院的临床癫痫门诊就诊之前,参与者会被邀请通过短信预约链接完成在线筛查工具:在 1081 名癫痫患者(955 名成人,126 名儿科患者)中,38.2% 的成人和 51.6% 的儿科患者照护者使用了 ePROM,完成率分别为 15% 和 14%。成人报告了轻度至严重焦虑(37.4%)、轻度至重度抑郁症状(29.2%),偶尔出现精神病症状(11.1%)。自述有精神症状的成年人报告的癫痫发作次数、发作负担、失眠、自闭症和多动症特征明显较高,生活质量和感知到的社会支持也较低。在报告有精神症状的患者中,只有 21% 接受过任何形式的心理健康支持。很大一部分儿科患者有情绪/行为障碍(32%)、高度冲动(38.8%)、自卑(27.7%)、睡眠障碍(50%)、合并神经发育综合征(27.7%)。两组受试者的社会支持水平均较高:我们根据癫痫病改编的 IMPARTS 电子病历管理系统可远程筛查精神健康症状、神经发育和复原力因素。将这些工具整合到电子病历中可提高早期识别能力,并促进转诊至适当的护理途径。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
ACS Applied Bio Materials
ACS Applied Bio Materials Chemistry-Chemistry (all)
CiteScore
9.40
自引率
2.10%
发文量
464
期刊最新文献
A Systematic Review of Sleep Disturbance in Idiopathic Intracranial Hypertension. Advancing Patient Education in Idiopathic Intracranial Hypertension: The Promise of Large Language Models. Anti-Myelin-Associated Glycoprotein Neuropathy: Recent Developments. Approach to Managing the Initial Presentation of Multiple Sclerosis: A Worldwide Practice Survey. Association Between LACE+ Index Risk Category and 90-Day Mortality After Stroke.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1